Liraglutide Effect on Weight and A1C in Patients with Type 2 Diabetes Mellitus: Real-World Data from a Single Tertiary Care Center in Saudi Arabia
Liraglutide reduced HbA1c levels and weight and affected multiple metabolic markers in patients with T2DM in a real-world setting in Saudi Arabia.
Authors
- Yousef Al‐Saleh (ORCID: https://orcid.org/0000-0002-5875-0950)
- Moeber Mahzari (ORCID: https://orcid.org/0000-0002-6796-9428)
- Emad Masuadi
- Mohammed Zaid Aljulifi (ORCID: https://orcid.org/0000-0002-1401-5305)
- Rasha M Alarfaj
- Rakan AlEnezi
- Abdullah Al Ruqaib
- Awadh AlRashidi
- Munirah AlFaraj
Institutions
- Qassim University (SA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Majmaah University (SA)
- United Arab Emirates University (AE)
- King Fahd Hospital of the University (SA)
- King Abdulaziz Medical City (SA)
- King Abdullah International Medical Research Center (SA)
- National Guard Health Affairs (SA)
- Imam Abdulrahman Bin Faisal University (SA)
Publication Details
- Journal
- Journal of Pharmacy And Bioallied Sciences
- Published
- 2024-08-12
- DOI
- https://doi.org/10.4103/jpbs.jpbs_473_24
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00